Primary Job Title Chief Operating Officer Primary Organization 
Stemline Therapeutics
Gender Male
LinkedIn View on LinkedIn
Kenneth Hoberman is Chief Operating Officer of Stemline Therapeutics.
Mr. Hoberman was previously Vice President of Corporate and Business Development of Keryx Biopharmaceuticals, Inc., where he was instrumental in securing multiple sources of capital including over $200 million in equity investments through public and private offerings. He also
initiated and executed a $100 million strategic alliance and originated, negotiated and closed dozens of licensing and operational contracts, and helped grow the company to a $900 million market capitalization at its peak.
Previously, he was Managing Director at Hawkins BioVentures, a healthcare advisory firm and has served as a consultant to various healthcare-related companies.
Mr. Hoberman received a B.S.B.A. in Finance from Boston University and completed post-baccalaureate studies at Columbia University.
